Latest Breaking News On - Regeneron pharmaceuticals daily - Page 13 : comparemela.com

Abbrea Capital LLC Buys Shares of 268 Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Abbrea Capital LLC Buys Shares of 268 Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Arthurf ryanAndrewj murphyGlobal retirement partnersRegeneron pharmaceuticals incRegeneron pharmaceuticals price performanceSecurities exchange commissionQuarter for regeneron pharmaceuticalsMorgan stanleyPark place capital corpRegeneron pharmaceuticalsRoyal bankCantor fitzgeraldNews ratings for regeneron pharmaceuticals dailyAdvisors incAbbrea capitalFree report

Abbrea Capital LLC Invests $235,000 in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Abbrea Capital LLC Invests $235,000 in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Marion mccourtAndrewj murphySanfordc bernsteinQuarter for regeneron pharmaceuticalsRegeneron pharmaceuticals incSecurities exchange commissionFortitude family officeExchange commissionAnnis gardner whiting capital advisorsSutton wealth advisors incRegeneron pharmaceuticalsNews ratings for regeneron pharmaceuticals dailyRegeneron pharmaceuticals company profileAbbrea capitalRegeneron pharmaceuticals trading downCriterion capital advisors

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) is Cutter & CO Brokerage Inc s 9th Largest Position

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) is Cutter & CO Brokerage Inc s 9th Largest Position
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMarion mccourtAndrewj murphySanfordc bernsteinCutter co brokerage incQuarter for regeneron pharmaceuticalsRonald blue trust incPark place capital corpInsider transactions at regeneron pharmaceuticalsGlobal retirement partnersRegeneron pharmaceuticals stockRegeneron pharmaceuticals company profileAdvisors incRoyal bankNews ratings for regeneron pharmaceuticals dailyRegeneron pharmaceuticals

730 Shares in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Acquired by GAMMA Investing LLC

GAMMA Investing LLC bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 730 shares of the biopharmaceutical company’s stock, valued at approximately $688,000. A number of other institutional investors have also made changes to their positions in REGN. Meyer Handelman […]

Andrewj murphySanfordc bernsteinArthurf ryanRegeneron pharmaceuticalsMorgan stanleyNews ratings for regeneron pharmaceuticals dailyRegeneron pharmaceuticals incStifel financial corpCavalier investmentsMeyer handelman coQuarter for regeneron pharmaceuticalsExchange traded conceptsRegeneron pharmaceuticals company profileRegeneron pharmaceuticals price performanceHoldings channelGamma investing

GAMMA Investing LLC Acquires New Holdings in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

GAMMA Investing LLC acquired a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 730 shares of the biopharmaceutical company’s stock, valued at approximately $688,000. Other institutional investors and hedge funds have […]

Andrewj murphyMarion mccourtRegeneron pharmaceuticals incNews ratings for regeneron pharmaceuticals dailyCantor fitzgeraldQuarter for regeneron pharmaceuticalsRegeneron pharmaceuticals stock performanceMorgan stanleyRegeneron pharmaceuticalsRegeneron pharmaceuticals profileBruceg allen investmentsFortitude family officeGamma investingCriterion capital advisorsAnnis gardner whiting capital advisorsFree report